Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk

Int J Mol Sci. 2023 Jan 4;24(2):996. doi: 10.3390/ijms24020996.

Authors

Sabata Pierno¹, Olimpia Musumeci²

Affiliations

¹ Section of Pharmacology, Department of Pharmacy and Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.
² Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

Abstract

Lipid-lowering drugs are widely used for the prevention and cure of cardiovascular diseases (CVD) [...].

Publication types

Editorial

MeSH terms

Cardiovascular Diseases* / drug therapy
Cardiovascular Diseases* / prevention & control
Humans
Hypolipidemic Agents / therapeutic use
Lipids
Risk Factors

Substances

Hypolipidemic Agents
Lipids